Opportunity Information: Apply for CDC RFA EH14 1408PPHF14
Apply for CDC RFA EH14 1408PPHF14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "PPHF 2014 Lead Poisoning Prevention Childhood Lead Poisoning Prevention financed solely by 2014 Prevention and Public Health Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.753 Child Lead Poisoning Prevention Surveillance financed in part by Prevention and Public Health (PPHF) Program.
- This funding opportunity was created on Jun 18, 2014 and posted on Jun 18, 2014.
- Applicants must submit their applications by Jul 22, 2014 Dates 1. Letter of Intent (LOI) Deadline June 30, 2014 via email to Kimball F. Credle, Project Officer, kfc2@cdc.gov 2. Application Deadline July 22, 2014, 1159 p.m. U.S. Eastern Standard Time, on www.grants.gov 3. Informational conference call for potential applicants n/a. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $33,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 41 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- A. Eligibility Information 1. Eligible Applicants Government Organizations State or their bona fide agents (includes the District of Columbia) Large cities or their bona fide agents 2. Special Eligibility Requirements N/A 3. Justification for Less than Maximum Competition This FOA is limited to State Governments or their Bona Fide Agents and Local Governments or their Bona Fide Agents. Large cities must have a valid limit population size of at least 750,000 using 2010 U.S. Census data or a 2011 2013 U.S. Census data update. To appropriately follow up on cases of lead poisoning and proactively prevent additional cases, awardees must have the authority in their jurisdiction to address case management activities that may involve Medicaid, housing, environmental regulation, or consumer protection agencies. Awardees must be able to assure that follow up care is provided for children identified with elevated blood lead levels and that elimination or control of lead hazards occurs within their jurisdictions. State and local governments are the only entities with these required authorities to achieve the mission of the FOA. The FOA requires applicants to demonstrate the burden of lead poisoning in their jurisdictions and the current request would allow for focusing of limited resources to states and local entities that have the greatest ability to address the housing, environmental, consumer and health care factors that contribute to childhood lead poisoning.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The PPHF 2014 Lead Poisoning Prevention: Childhood Lead Poisoning Prevention grant opportunity (Funding Opportunity Number CDC RFA EH14-1408PPHF14) was a CDC discretionary funding announcement that used 2014 Prevention and Public Health Fund (PPHF) dollars to strengthen and modernize how states and certain large cities track, target, and prevent childhood lead poisoning. Rather than focusing only on maintaining traditional surveillance, the announcement emphasized using surveillance as an action tool: collecting and improving blood lead level (BLL) data, analyzing it to find the highest-risk neighborhoods and exposure pathways, and then driving population-based primary prevention interventions in the places with the greatest need. The overall public health aim was not simply to respond to individual cases, but to prevent exposures in the first place and move toward eliminating childhood lead poisoning as a major public health problem.
At its core, the FOA asked applicants to build or enhance surveillance capacity that could do two practical things. First, it required jurisdictions to use surveillance data to identify remaining geographic “hot spots” where children continue to have elevated BLLs and where lead hazards are likely persisting, especially in older housing and other high-risk environments. Second, it expected jurisdictions to use those same data systems to evaluate case management performance, particularly whether children identified with high BLLs are being reached quickly, connected to follow-up care, and receiving timely environmental investigation and hazard control. In other words, data quality and data use were treated as inseparable: better data should lead directly to better targeting of prevention resources and faster, more effective follow-up for affected children.
The prevention strategies encouraged under this opportunity reflected a primary prevention, community-level approach. The announcement highlighted interventions such as housing rehabilitation and lead hazard control, stronger enforcement of housing and health codes, and coordinated work with health care systems to improve screening, reporting, referral, and follow-up. It also explicitly recognized that lead exposure is not limited to paint and housing, calling for public and provider education campaigns addressing other sources of contamination, including imported products. The FOA also noted a policy-related use of surveillance data: jurisdictions could use data to help designate areas as “lead safe” and to support applications for a universal blood lead testing waiver through Medicaid, implying that robust local data could justify shifts in screening policy where risk is demonstrably low.
Funding was provided through cooperative agreements, meaning CDC anticipated substantial programmatic involvement beyond a typical grant, such as technical assistance, guidance on surveillance practices, and alignment with national childhood lead poisoning prevention goals. The announcement listed an estimated total funding amount of $33,000,000 and indicated expected awards of 41, with an award ceiling of $500,000 and no cost-sharing or matching requirement. Although the narrative description referenced approximately $11 million in awards for the surveillance-to-intervention approach, the posted opportunity-level totals reflected a larger overall funding figure for the program under this FOA listing.
Eligibility was intentionally limited to government entities with the legal authority and operational reach to carry out both the health and environmental components of lead poisoning prevention. Eligible applicants were state governments (including the District of Columbia) or their bona fide agents, and large cities or their bona fide agents. Large cities had to meet a population threshold of at least 750,000 based on 2010 Census data or later Census updates referenced in the announcement. The rationale for limiting competition was practical: to follow up on lead poisoning cases and prevent new ones, awardees must be able to coordinate or direct activities involving Medicaid, housing agencies, environmental regulation, and consumer protection, and they must be able to ensure that children with elevated BLLs receive follow-up services and that lead hazards are controlled within the jurisdiction. The FOA also signaled an intent to prioritize places with demonstrated burden and with the ability to address the housing, environmental, consumer, and health care factors that drive childhood lead exposure.
Key administrative details included a posted and creation date of June 18, 2014, a letter of intent deadline of June 30, 2014 (submitted by email to the CDC project officer), and an application deadline of July 22, 2014 at 11:59 p.m. Eastern Time via Grants.gov. The opportunity was archived on August 21, 2014. For technical issues accessing the announcement, CDC’s Procurement and Grants Office Technical Information Management Section was listed as the contact point.
Taken together, the opportunity can be understood as a push to move childhood lead poisoning programs from passive tracking to active prevention: improving surveillance systems so they not only measure elevated BLLs, but also pinpoint where and why exposures are happening, trigger cross-sector interventions to remove hazards, and verify that case management and environmental responses are timely and effective.
FAQs: PPHF 2014 Lead Poisoning Prevention: Childhood Lead Poisoning Prevention (CDC RFA EH14-1408PPHF14)
What is this funding opportunity?
This is the CDC discretionary funding announcement titled PPHF 2014 Lead Poisoning Prevention: Childhood Lead Poisoning Prevention, Funding Opportunity Number CDC RFA EH14-1408PPHF14. It used 2014 Prevention and Public Health Fund (PPHF) dollars to strengthen and modernize how states and certain large cities track, target, and prevent childhood lead poisoning.
What is the main goal of the program?
The goal is to move programs beyond passive tracking of blood lead levels and toward primary prevention at a population level. The focus is on preventing exposures in the first place and working toward eliminating childhood lead poisoning as a major public health problem.
How is surveillance expected to be used under this FOA?
The FOA emphasized using surveillance as an action tool, not only as a reporting system. Applicants were expected to collect and improve blood lead level (BLL) data, analyze it to identify risk patterns, and use it to drive prevention actions in the highest-need places.
What two practical outcomes did the FOA require surveillance capacity to support?
The FOA centered surveillance capacity around two practical outcomes:
- Identify geographic hot spots where children continue to have elevated BLLs and where lead hazards likely persist (especially in older housing and other high-risk environments).
- Evaluate case management performance, including whether children with high BLLs are contacted quickly, connected to follow-up care, and receive timely environmental investigation and hazard control.
What types of prevention strategies were encouraged?
The FOA encouraged a primary prevention, community-level approach. Examples included housing rehabilitation and lead hazard control, stronger enforcement of housing and health codes, and coordination with health care systems to improve screening, reporting, referral, and follow-up.
Did the FOA focus only on lead paint and housing?
No. While older housing and related hazards were clearly emphasized, the FOA explicitly recognized that lead exposure is not limited to paint and housing. It called for education efforts addressing other contamination sources, including imported products.
How were data quality and data use treated in the announcement?
Data quality and data use were treated as inseparable. The FOA’s expectation was that better data should directly lead to better targeting of prevention resources and faster, more effective follow-up for affected children.
What role did case management and environmental response play in the FOA?
The FOA highlighted using surveillance systems to assess whether case management is working as intended, especially whether children with elevated BLLs are reached promptly and whether environmental investigations and hazard controls occur in a timely way.
How could surveillance data be used for policy or designation purposes?
The FOA noted that jurisdictions could use surveillance data to help designate areas as "lead safe" and to support applications for a universal blood lead testing waiver through Medicaid, where local data demonstrate low risk.
What type of award mechanism was used?
Funding was provided through cooperative agreements. That means CDC anticipated substantial programmatic involvement, such as technical assistance, guidance on surveillance practices, and alignment with national childhood lead poisoning prevention goals.
What was the estimated total funding amount?
The announcement listed an estimated total funding amount of $33,000,000.
How many awards were expected?
The FOA indicated 41 expected awards.
What was the maximum award amount (award ceiling)?
The award ceiling was listed as $500,000.
Was cost-sharing or matching required?
No. The FOA indicated no cost-sharing or matching requirement.
Why does the description mention about $11 million when the total is listed as $33 million?
The narrative description referenced approximately $11 million in awards for the surveillance-to-intervention approach, while the posted opportunity-level totals reflected a larger overall figure of $33,000,000 for the program under this FOA listing.
Who was eligible to apply?
Eligibility was limited to government entities with the legal authority and operational reach to carry out both health and environmental components of lead poisoning prevention. Eligible applicants were:
- State governments (including the District of Columbia) or their bona fide agents
- Large cities or their bona fide agents
What qualified as a "large city" for eligibility?
A large city had to meet a population threshold of at least 750,000 based on 2010 Census data or later Census updates referenced in the announcement.
Why was eligibility limited to states and certain large cities?
The rationale was practical: to follow up on lead poisoning cases and prevent new ones, awardees must be able to coordinate or direct work involving Medicaid, housing agencies, environmental regulation, and consumer protection, and they must be able to ensure both follow-up services for children and hazard control within the jurisdiction.
What kinds of cross-sector coordination did the FOA assume awardees could do?
The FOA assumed awardees could coordinate or direct activities involving systems like Medicaid, housing agencies, environmental regulation, consumer protection, and health care systems to support screening, reporting, referral, follow-up, investigation, and hazard control.
Did the FOA indicate anything about prioritizing certain places?
Yes. The FOA signaled an intent to prioritize places with a demonstrated burden of childhood lead exposure and with the ability to address housing, environmental, consumer, and health care factors driving exposure.
When was the opportunity posted?
The posted and creation date was June 18, 2014.
Was a letter of intent required, and when was it due?
A letter of intent deadline was listed as June 30, 2014, submitted by email to the CDC project officer.
When was the application due and how was it submitted?
The application deadline was July 22, 2014 at 11:59 p.m. Eastern Time, and applications were submitted via Grants.gov.
Is this funding opportunity still open?
No. The opportunity was archived on August 21, 2014.
Who was listed as the contact for technical issues accessing the announcement?
For technical issues accessing the announcement, the contact point listed was CDC’s Procurement and Grants Office Technical Information Management Section.
In plain terms, what was CDC trying to change with this FOA?
The FOA represented a shift from passive monitoring to active prevention: improving surveillance systems so they not only measure elevated BLLs, but also pinpoint where and why exposures are happening, trigger cross-sector interventions to remove hazards, and verify that follow-up and environmental responses are timely and effective.
Browse more opportunities from the same category: Health
Next opportunity: National Park Service YPP Intergovernmental Internship Cooperative Youth Partnership Project 2014
Previous opportunity: Scott River Water Trust Instream Water Leasing
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA EH14 1408PPHF14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA EH14 1408PPHF14) also looked into and applied for these:
| Funding Opportunity |
|---|
| Grants to Support the Historically Black Colleges and Universities Health Services Research Grant Program Apply for CMS 1I0 14 001 Funding Number: CMS 1I0 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 14 001 Funding Number: CMS 1H0 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Service Area Competition Apply for HRSA 15 008 Funding Number: HRSA 15 008 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 009 Funding Number: HRSA 15 009 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIMH Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp) Apply for PA 14 263 Funding Number: PA 14 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Promoting Preventive Health Services for Women Apply for HRSA 14 084 Funding Number: HRSA 14 084 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| NINDS Direct Phase II SBIR Grants to Support Exploratory Clinical Trials Apply for PAR 14 265 Funding Number: PAR 14 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg) Apply for CDC RFA PS15 1501 Funding Number: CDC RFA PS15 1501 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,304,252 |
| Reproductive and Environmental Health Network Apply for HRSA 14 147 Funding Number: HRSA 14 147 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Mesothelioma Virtual Bank for Translational Research (U24) Apply for RFA OH 14 010 Funding Number: RFA OH 14 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,100,000 |
| Enriching the Hematology Research Workforce through Short term Educational Experiences in Emerging Science Research Education Program Grant (R25) Apply for RFA HL 15 006 Funding Number: RFA HL 15 006 Agency: National Institutes of Health Category: Health Funding Amount: $115,000 |
| Center of Excellence for Natural Product Drug Interaction Research (U54) Apply for RFA AT 15 001 Funding Number: RFA AT 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,400,000 |
| Development of Novel Therapeutics for Select Pathogens (R21/R33) Apply for RFA AI 14 026 Funding Number: RFA AI 14 026 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Service Area Competition Apply for HRSA 15 010 Funding Number: HRSA 15 010 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 15 011 Funding Number: HRSA 15 011 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Comparative Health System Performance in Accelerating PCOR Dissemination (U19) Apply for RFA HS 14 011 Funding Number: RFA HS 14 011 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $3,500,000 |
| Community Package of High Impact Interventions Apply for USAID BENIN 680 14 00002 RFA Funding Number: USAID BENIN 680 14 00002 RFA Agency: Benin USAID Cotonou Category: Health Funding Amount: $2,400,000 |
| Alliance for Innovation on Maternal and Child Health Cooperative Agreement Expanding Access to Care for the Maternal and Child Health Population (Category 1 Collaborative Engagement) Apply for HRSA 14 011 Funding Number: HRSA 14 011 Agency: Health Resources and Services Administration Category: Health Funding Amount: $350,000 |
| Alliance for Innovation on Maternal and Child Health Cooperative Agreement Expanding Access to Care for the Maternal and Child Health Population(Category 2 Measuring Collaborative Engagement Awardee Activity) Apply for HRSA 14 141 Funding Number: HRSA 14 141 Agency: Health Resources and Services Administration Category: Health Funding Amount: $250,000 |
| Innovative Assays to Quantify the Latent HIV Reservoir (R01) Apply for RFA AI 14 020 Funding Number: RFA AI 14 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA EH14 1408PPHF14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.